Role of aspirin in primary prevention of cardiovascular disease
The benefits of aspirin therapy for the secondary prevention of cardiovascular disease clearly outweigh the risks of bleeding, and low-dose aspirin is uniformly recommended in this setting. However, no clear consensus exists about whether, and if so in whom, aspirin therapy is appropriate for the pr...
Huvudupphovsmän: | Patrono, C, Baigent, C |
---|---|
Materialtyp: | Journal article |
Språk: | English |
Publicerad: |
Springer Nature
2019
|
Liknande verk
Liknande verk
-
Selective cyclooxygenase 2 inhibitors, aspirin, and cardiovascular disease: a reappraisal.
av: Baigent, C, et al.
Publicerad: (2003) -
Low-dose aspirin for the prevention of atherothrombosis.
av: Patrono, C, et al.
Publicerad: (2005) -
Drug therapy - Low-dose aspirin for the prevention of atherothrombosis
av: Patrono, C, et al.
Publicerad: (2005) -
Antiplatelet therapy: aspirin for asymptomatic atherosclerosis?
av: Patrono, C, et al.
Publicerad: (2010) -
Prevention. Aspirin in primary prevention--good news and bad news.
av: Hennekens, C, et al.
Publicerad: (2012)